Scripps Joins Primary Human Tumor Consortium | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Scripps Translational Science Institute has joined the Primary Human Tumor Consortium, an effort to build a library of primary human tumors, Jackson Laboratory announced this week.

The goal of PHTC, which is being headed by Jackson Lab, is to develop highly targeted cancer therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.